Praxis Investment Management Inc. Sells 170 Shares of Plexus Corp. (NASDAQ:PLXS)

Praxis Investment Management Inc. lessened its holdings in Plexus Corp. (NASDAQ:PLXS) by 3.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,250 shares of the technology company’s stock after selling 170 shares during the quarter. Praxis Investment Management Inc.’s holdings in Plexus were worth $545,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. TD Private Client Wealth LLC purchased a new stake in shares of Plexus in the 4th quarter worth approximately $28,000. Aquatic Capital Management LLC boosted its holdings in Plexus by 134.0% in the fourth quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company’s stock worth $37,000 after acquiring an additional 134 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its stake in shares of Plexus by 45.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company’s stock worth $50,000 after acquiring an additional 100 shares during the last quarter. Versant Capital Management Inc grew its stake in shares of Plexus by 1,000.0% in the first quarter. Versant Capital Management Inc now owns 473 shares of the technology company’s stock worth $61,000 after acquiring an additional 430 shares during the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of Plexus by 49.2% during the first quarter. Blue Trust Inc. now owns 846 shares of the technology company’s stock valued at $108,000 after acquiring an additional 279 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.

Insider Buying and Selling

In other Plexus news, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $130.77, for a total transaction of $65,385.00. Following the completion of the sale, the director now directly owns 9,365 shares in the company, valued at $1,224,661.05. The trade was a 5.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Patrick John Jermain sold 4,328 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $132.29, for a total transaction of $572,551.12. Following the completion of the transaction, the chief financial officer now owns 25,637 shares in the company, valued at $3,391,518.73. This trade represents a 14.44% decrease in their position. The disclosure for this sale can be found here. Insiders sold 12,032 shares of company stock valued at $1,582,222 over the last 90 days. Company insiders own 1.76% of the company’s stock.

Plexus Price Performance

PLXS opened at $130.71 on Friday. The company’s 50-day simple moving average is $128.96 and its two-hundred day simple moving average is $138.23. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.53. The stock has a market capitalization of $3.54 billion, a P/E ratio of 25.43 and a beta of 0.81. Plexus Corp. has a 52-week low of $100.96 and a 52-week high of $172.89.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.12. Plexus had a net margin of 3.60% and a return on equity of 11.17%. The company had revenue of $980.17 million for the quarter, compared to the consensus estimate of $980.07 million. During the same quarter in the prior year, the firm earned $0.94 earnings per share. The firm’s revenue for the quarter was up 1.4% compared to the same quarter last year. As a group, analysts predict that Plexus Corp. will post 5.9 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on PLXS shares. Stifel Nicolaus set a $145.00 price target on shares of Plexus in a research note on Thursday, April 24th. Benchmark reiterated a “buy” rating and issued a $160.00 target price on shares of Plexus in a research note on Wednesday, June 4th. Needham & Company LLC reiterated a “buy” rating and set a $162.00 price target (down previously from $172.00) on shares of Plexus in a report on Friday, April 25th. Finally, Wall Street Zen lowered shares of Plexus from a “strong-buy” rating to a “buy” rating in a report on Sunday. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Plexus has a consensus rating of “Moderate Buy” and a consensus price target of $155.67.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.